July 2012 - FRMC

Tamoxifen Therapy for 10 Years versus 5 Years

07/22/2013

Tim Casey

Chicago—Patients who took tamoxifen for 10 years had a reduced disease recurrence and breast cancer mortality compared with a group receiving the drug for 5 years, according to a randomized, phase 3 trial that began >20 years ago. The...

Chicago—Patients who took...

07/22/2013

First Report Managed Care

Novel Monoclonal Antibody to PCSK9

07/23/2012

Kevin L. Carter

Studies of animal models have found that proprotein convertase subtilisin/kexin 9 (PCSK9), one of the serine proteases, has a role in the post-translational regulation of LDL-receptor activity. PCSK9, which is synthesized primarily in the...

Studies of animal models have...

07/23/2012

First Report Managed Care

Bosutinib versus Imatinib in Treating Chronic Myeloid Leukemia

07/23/2012

Tim Casey

Chicago—After 30 months, patients with Philadelphia chromosome-positive chronic phase chronic myeloid leukemia who took bosutinib had superior efficacy and safety results compared with those who received imatinib, according to updated...

Chicago—After 30 months,...

07/23/2012

First Report Managed Care

Continuous Therapy in Prostate Cancer Patients

07/23/2012

Tim Casey

Chicago—A phase 3, international, randomized trial of patients with hormone-sensitive metastatic prostate cancer found that overall survival was inferior in those who had intermittent androgen deprivation therapy compared with those who...

Chicago—A phase 3,...

07/23/2012

First Report Managed Care

Orteronel to Treat Nonmetastatic Castration-Resistant Prostate Cancer

07/23/2012

Tim Casey

Chicago—An analysis of an ongoing phase 2 study found that patients with nonmetastatic, castration-resistant prostate cancer (nmCRPC) and rising prostate-specific antigen (PSA) reacted well to and managed toxicities when taking orteronel, an...

Chicago—An analysis of an...

07/23/2012

First Report Managed Care

T-DM1 Superior to Capecitabine plus Lapatinib in Advanced Breast Cancer

07/23/2012

Tim Casey

Chicago—The first phase 3 study to evaluate trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer found that the investigational antibody drug conjugate had superior efficacy and safety compared with an...

Chicago—The first phase 3 study...

07/23/2012

First Report Managed Care

Nab-Paclitaxel, Ixabepilone Not Superior to Paclitaxel

07/23/2012

Tim Casey

Chicago—A phase 3 study found that nab-paclitaxel and ixabepilone were not superior to standard treatment (paclitaxel) in patients with chemotherapy-naïve metastatic breast cancer who also received bevacizumab. Hope S. Rugo, MD, professor of...

Chicago—A phase 3 study found...

07/23/2012

First Report Managed Care

Afatinib Effective in Treating Late-Stage NSCLC

07/23/2012

Tim Casey

Chicago—Patients with advanced stage non–small cell lung cancer (NSCLC) who took the investigational oral agent afatinib had a significantly longer progression-free survival compared with those who received a standard combination chemotherapy...

Chicago—Patients with advanced...

07/23/2012

First Report Managed Care

Nausea and Vomiting in Cancer Patients

07/23/2012

Tim Casey

Orlando—When cancer patients undergo chemotherapy treatments, they face numerous challenges, among them nausea and vomiting. Physicians and nurses sometimes underestimate how many patients will have these side effects, according to Charles...

Orlando—When cancer patients...

07/23/2012

First Report Managed Care

News

Integrated Genetic Profiling in Acute Myeloid Leukemia

07/23/2012

Kevin L. Carter

A series of somatic mutations that affect the progression and development of acute myeloid leukemia (AML) has recently been discovered. The prognostic relevance of cytogenetic abnormalities has led to the widespread adoption of risk...

A series of somatic mutations...

07/23/2012

First Report Managed Care

Current Issue

June 2024

Volume 21

Issue 2

Current Issue

Issue Archive

What's Trending?

Conference Insider

Managing Chronic Kidney Disease in Older Adults

11/03/2014

Eileen Koutnik-Fotopoulos

Chronic kidney disease is pervasive in the older population. The progression of CKD can have a significant affect on the overall prognosis of a geriatric patient.

Chronic kidney disease is...

11/03/2014

First Report Managed Care

News

Retirement, health insurance commonly targeted

08/04/2011

First Report Managed Care

News

US Government Proposes More Transparency in Clinical Trials

11/19/2014

Health officials proposed significantly expanding what researchers are required to report about clinical trials of drugs, devices, and other interventions.

Health officials proposed...

11/19/2014

First Report Managed Care

News

Device Could Reduce Direct Medical Costs For Patients with COPD

11/15/2017

Recent research in the International Journal of COPD found that a handheld mechanical oscillating positive expiratory pressure device could significantly improve post-exacerbation care.

Recent research in...

11/15/2017

First Report Managed Care

News

Pelosi: Public option will not be in health bill despite liberal efforts

03/12/2010

First Report Managed Care

Video Insights

Videos

Evolving Health Care Contact Centers Into Drivers of Value-Based Care

07/31/2024

Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.

Discover how health care contact...

07/31/2024

First Report Managed Care

Videos

Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024

06/11/2024

Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations

Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...

Key stakeholders in the health...

06/11/2024

First Report Managed Care

Melissa Andel, Principal, CommonHealth Solutions, LLC

Videos

Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers

05/24/2024

Melissa Andel, Principal, CommonHealth Solutions, LLC

Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.

Learn about the impacts of the...

05/24/2024

First Report Managed Care

Videos

Navigating Payment Models in the CGT Landscape: Insights and Innovations

05/21/2024

Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson

An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.

An expert discusses the...

05/21/2024

First Report Managed Care

Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP

Videos

Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations

05/15/2024

Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP

Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.

Learn about developments in...

05/15/2024

First Report Managed Care

Videos

Personalizing Weight Loss Management With GLP-1 Agonists

04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc

Featuring Tejaswi Kompala, MD, head o...

Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.

Delve into the rising demand for...

04/05/2024

First Report Managed Care

Videos

Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health

03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...

Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...

Join us for the continuation of...

03/27/2024

First Report Managed Care

Videos

Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care

03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...

Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...

Come join us for the first...

03/25/2024

First Report Managed Care

Videos

Navigating the Evolution of Digital Solutions in Health Care

02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates

Featuring Yash Prajapati, consultant ...

Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.

Join us in exploring the...

02/27/2024

First Report Managed Care

Videos

Advancements and Challenges in Diabetes Management

02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health

Featuring Mansur Shomali, MD, chief m...

Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.

July 2012 - FRMC

News

Current Issue

What's Trending?

Video Insights

Subscribe to our eNewsletters!

July 2012 Volume 9 Issue 7

Specialties

Events

Year Round Education

HMP Global Products